{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T20:38:00Z","timestamp":1775507880506,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.atherosclerosis.2009.09.022","type":"journal-article","created":{"date-parts":[[2009,9,21]],"date-time":"2009-09-21T04:09:32Z","timestamp":1253506172000},"page":"300-305","source":"Crossref","is-referenced-by-count":46,"title":["Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome"],"prefix":"10.1016","volume":"209","author":[{"given":"Nevio","family":"Taglieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Fernandez-Berges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Consuegra-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Maria Cruz","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas Roberto","family":"Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Luis","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso Castro","family":"Beiras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Maria Montes","family":"Orbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Kaski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"November (17)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"issue":"February (2 Suppl. 1)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"October (17)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib3","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"issue":"September (13)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"September (13)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"issue":"December (25)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib6","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIRCULATIONAHA.108.792903","article-title":"Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study","volume":"118","author":"Ninomiya","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.09.022_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2009.09.022_bib8","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1373\/clinchem.2005.051557","article-title":"Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan\u2013Barratt prediction equations for children","volume":"51","author":"Grubb","year":"2005","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.09.022_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/00365510510013596","article-title":"A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula","volume":"65","author":"Grubb","year":"2005","journal-title":"Scand J Clin Lab Invest"},{"issue":"January (2)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCULATIONAHA.106.644286","article-title":"Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study","volume":"115","author":"Ix","year":"2007","journal-title":"Circulation"},{"issue":"May (20)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib11","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N Engl J Med"},{"issue":"January (2)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jacc.2004.09.061","article-title":"Cystatin-C and mortality in elderly persons with heart failure","volume":"45","author":"Shlipak","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.09.022_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1681\/ASN.2005050545","article-title":"Cystatin C and mortality risk in the elderly: the health, aging, and body composition study","volume":"17","author":"Shlipak","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"October (19)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib14","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the global registry of acute coronary events","volume":"163","author":"Granger","year":"2003","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.09.022_bib15","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/eurheartj\/ehm004","article-title":"Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better","volume":"28","author":"Yan","year":"2007","journal-title":"Eur Heart J"},{"issue":"October (16)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib16","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000145166.44942.E0","article-title":"Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome","volume":"110","author":"Jernberg","year":"2004","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.09.022_bib17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1023\/B:EJEP.0000040531.77638.17","article-title":"Regional variability in population acute myocardial infarction cumulative incidence and mortality rates in Spain 1997 and 1998","volume":"19","author":"Marrugat","year":"2004","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2009.09.022_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1157\/13045655","article-title":"Inflammation markers and risk stratification in patients with acute coronary syndromes: design of the SIESTA Study (systemic inflammation evaluation in patients with non-ST segment elevation acute coronary syndromes)","volume":"56","author":"Kaski","year":"2003","journal-title":"Rev Esp Cardiol"},{"issue":"October (7)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib19","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0735-1097(02)02336-7","volume":"40","author":"Braunwald","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2009.09.022_bib20","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1053\/euhj.2002.3385","article-title":"Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"23","author":"Bertrand","year":"2002","journal-title":"Eur Heart J"},{"issue":"October (6)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"July (2)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2009.09.022_bib23","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1097\/01.ASN.0000095642.25603.7A","article-title":"Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study","volume":"14","author":"Ix","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2009.09.022_bib24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/eurheartj\/ehn598","article-title":"Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study","volume":"30","author":"Keller","year":"2009","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.09.022_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1373\/clinchem.2004.041889","article-title":"Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate","volume":"51","author":"Koenig","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2009.09.022_bib26","first-page":"9","article-title":"Cystatin C for Enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T","author":"Windhausen","year":"2009","journal-title":"Clin Chem"},{"issue":"August (7)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"issue":"August (4)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/0003-4819-145-4-200608150-00003","article-title":"Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease","volume":"145","author":"Shlipak","year":"2006","journal-title":"Ann Intern Med"},{"issue":"January (1)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-140-1-200401060-00006","article-title":"The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease","volume":"140","author":"Muntner","year":"2004","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2009.09.022_bib30","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.amjmed.2005.07.060","article-title":"Cystatin-C and inflammatory markers in the ambulatory elderly","volume":"118","author":"Shlipak","year":"2005","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2009.09.022_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.ATV.0000117180.57731.36","article-title":"Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease","volume":"24","author":"Eriksson","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"August (3)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1172\/JCI181","article-title":"Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells","volume":"102","author":"Sukhova","year":"1998","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2009.09.022_bib33","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.ATV.0000134530.27208.41","article-title":"Lysosomal cysteine proteases in atherosclerosis","volume":"24","author":"Liu","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.09.022_bib34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1172\/JCI7709","article-title":"Cystatin C deficiency in human atherosclerosis and aortic aneurysms","volume":"104","author":"Shi","year":"1999","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2009.09.022_bib35","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/01.ATV.0000179600.34086.7d","article-title":"Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice","volume":"25","author":"Bengtsson","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"August (33)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib36","doi-asserted-by":"crossref","first-page":"34776","DOI":"10.1074\/jbc.M310814200","article-title":"Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro","volume":"279","author":"Oorni","year":"2004","journal-title":"J Biol Chem"},{"issue":"January (1)","key":"10.1016\/j.atherosclerosis.2009.09.022_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.105.561449","article-title":"Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation","volume":"113","author":"Lutgens","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2009.09.022_bib38","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/01.ATV.0000203526.75772.4b","article-title":"Destabilizing role of cathepsin S in murine atherosclerotic plaques","volume":"26","author":"Rodgers","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009007357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009007357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T15:01:59Z","timestamp":1558537319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915009007357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0021915009007357"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.09.022","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}